DISCO Pharmaceuticals

Recursion Pharma

This company provides a technology platform for drug discovery and development to pharmaceutical partners and develops internal therapeutic candidates for patients with unmet medical needs.

TwoStep Therapeutics

The company develops peptide-drug conjugates and targeted therapies for patients with solid tumours.

Waypoint Bio

This company develops cell therapies for solid tumours using a spatial biology and machine learning platform to assist patients with difficult-to-treat cancers.

D3 Bio

This biotechnology company develops precision medicines and oncology therapeutics for patients with cancer and immunological conditions.

Tango Therapeutics

This biotechnology company develops precision oncology medicines targeting genetic vulnerabilities in cancer cells for patients with solid tumours.

Mosaic Biomedicals

This drug discovery company develops personalised cancer treatments targeting stem cells and the immune system for patients with solid tumours.

Vivere Oncotherapies

This company develops engineered cancer immunotherapies to help the immune systems of patients with solid tumours detect and destroy malignant cells.

PanCancerT

This biotech company develops T-cell receptor therapies for patients with solid tumours, focusing on targets like triple-negative breast cancer and melanoma.